ABMT (Advanced BioMedical Technologies) Cyclically Adjusted PS Ratio: (As of Jul. 13, 2026)


What is Advanced BioMedical Technologies Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Advanced BioMedical Technologies  (OTCPK:ABMT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Advanced BioMedical Technologies Cyclically Adjusted PS Ratio Related Terms


Advanced BioMedical Technologies Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Cyclically Adjusted PS Ratio Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ABMT vs VYCO, ADMT, THMO: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Cyclically Adjusted PS Ratio falls into.



Advanced BioMedical Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Advanced BioMedical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Jul. 2021 is calculated as:

For example, Advanced BioMedical Technologies's adjusted Revenue per Share data for the three months ended in Jul. 2021 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jul. 2021 (Change)*Current CPI (Jul. 2021)
=0/273.0030*273.0030
=0.000

Current CPI (Jul. 2021) = 273.0030.

Advanced BioMedical Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201110 0.000 226.421 0.000
201201 0.000 226.665 0.000
201204 0.000 230.085 0.000
201207 0.000 229.104 0.000
201210 0.000 231.317 0.000
201301 0.000 230.280 0.000
201304 0.000 232.531 0.000
201307 0.000 233.596 0.000
201310 0.000 233.546 0.000
201401 0.000 233.916 0.000
201404 0.000 237.072 0.000
201407 0.000 238.250 0.000
201410 0.000 237.433 0.000
201501 0.000 233.707 0.000
201504 0.000 236.599 0.000
201507 0.000 238.654 0.000
201510 0.000 237.838 0.000
201601 0.000 236.916 0.000
201604 0.000 239.261 0.000
201607 0.000 240.628 0.000
201610 0.000 241.729 0.000
201701 0.000 242.839 0.000
201704 0.000 244.524 0.000
201707 0.000 244.786 0.000
201710 0.000 246.663 0.000
201801 0.000 247.867 0.000
201804 0.000 250.546 0.000
201807 0.000 252.006 0.000
201810 0.000 252.885 0.000
201901 0.000 251.712 0.000
201904 0.000 255.548 0.000
201907 0.000 256.571 0.000
201910 0.000 257.346 0.000
202001 0.001 257.971 0.001
202004 0.000 256.389 0.000
202007 0.000 259.101 0.000
202010 0.001 260.388 0.001
202101 0.001 261.582 0.001
202104 0.000 267.054 0.000
202107 0.000 273.003 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.